Analysis Group, one of the largest economics consulting firms, is pleased to announce the promotions of Dave Nellesen to Principal and Dov Rothman to Managing Principal, and to welcome Vice President Claudio Calcagno and six new affiliates to the firm.
"As recognized leaders in their respective fields, Dave, Dov, and Claudio bring a diverse set of skills and experiences to many of our practice areas," said Martha S. Samuelson, CEO and Chairman of Analysis Group. "Among other endeavors, they have helped biotech and pharmaceutical companies with product development, approval, and reimbursement strategies; worked with regulatory agencies on some of the largest merger investigations; and advised clients on international antitrust and competition issues. We are also pleased to share the news of our affiliation with six esteemed academic and industry experts. Their impressive experience deepens the expertise we offer our clients in areas such as consumer decision making, the effects of government policies on the health care industry, the economics of medical innovation, digital marketing, entrepreneurial finance, and market research."
New Affiliates
Kurt Carlson – associate dean for faculty and academic affairs at the Mason School of Business at William & Mary – specializes in the marketing management implications of consumer decision-making processes, including the development of brand preferences and the influence of emerging preferences on the decision-making process. Though much of Professor Carlson's research explores consumer decision making, he also studies how voters, jurors, and managers make decisions. Over the last 20 years, he has run thousands of surveys, sampling US and international populations. Professor Carlson has served as an expert in evaluating a survey in a class action matter, consulted on a high profile class action settlement involving consumer deception, and testified before the SEC in an equity trust matter. Professor Carlson's published research can be found in top marketing, psychology, and management journals. He is also the coauthor of Contemporary Brand Management. He blogs for Psychology Today and Forbes, and maintains an active Twitter account (@ProfKurt). While teaching at Georgetown University between 2009 and 2017, Professor Carlson was director of the Georgetown Institute for Consumer Research and co-director of the McDonough School of Business Behavioral Research Lab. He has received the MSB Dean's Distinguished Faculty Research Award and the Decision Analysis Society's Publication Award.
Craig Garthwaite – Herman Smith Research Professor in Hospital and Health Services Management, associate professor of strategy, and director of healthcare at the Kellogg School of Management at Northwestern University – is an applied microeconomist who studies the effects of government policies and social phenomena, particularly in the areas of health and biopharmaceuticals. His recent work focuses on the private sector effects of the Affordable Care Act, including the labor supply effects of large insurance expansions, the changes in uncompensated hospital care resulting from public insurance expansions, and the responses of nonprofit hospitals to financial shocks. Professor Garthwaite also studies biopharmaceutical pricing and innovation, including the effect of expanded patent protection on pricing in the Indian pharmaceutical market, the effects of increases in demand on innovation by US pharmaceutical firms, and the relationship between health insurance expansions and high drug prices. Additionally, he studies the effects of the increased use of private firms to operate and manage social insurance programs, with a focus on Medicaid managed care firms. Professor Garthwaite has testified before the US House of Representatives and several state legislatures on the minimum wage, health care reforms, and consolidation in health care markets. He has also held several public policy positions, including faculty associate with Northwestern University's Institute for Policy Research and director of research for the Employment Policies Institute. Professor Garthwaite's research has appeared in journals such as The Quarterly Journal of Economics, American Economic Review, The Review of Economics and Statistics,and Health Affairs;and has been profiled in media outlets such as The New York Times, The Wall Street Journal, The Washington Post,and Vox. He has also appeared on various TV and radio programs, including Nightly Business Report and NPR Marketplace.
Anupam B. Jena – Ruth L. Newhouse Associate Professor of Health Care Policy at Harvard Medical School and a physician in Massachusetts General Hospital's Department of Medicine – is a health economist, practicing internal medicine physician, and professor of health care policy. His work involves several areas of health economics and policy, including the economics of medical innovation, the economics of physician behavior and the physician workforce, medical malpractice, and the economics of health care productivity. Professor Jena has been retained as an expert in several pharmaceutical and health care industry matters. A prolific author, Professor Jena has contributed to more than 150 peer-reviewed articles and articles intended to increase patient understanding, published in outlets including the New England Journal of Medicine and The New York Times. He is a faculty research fellow at the National Bureau of Economic Research and serves on Harvard Medical School's Standing Committee on Health Policy. Professor Jena is a recipient of the NIH Director's Early Independence Award to fund research on the physician determinants of health care spending, quality, and patient outcomes; and a recipient of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) New Investigator Award. In 2018, he was listed among 100 great leaders in health care by Becker's Hospital Review.
Anja Lambrecht – associate professor of marketing at London Business School – is an expert in digital marketing and consumer behavior. Her research focuses on marketing decisions in digital environments – emphasizing online targeting, advertising, promotion, and pricing. In the context of digital marketing, Professor Lambrecht has examined how firms can use retargeting to reach out to consumers; how firms can advertise on Twitter to early trend propagators; the role of position effects on information displayed to consumers online; and, more broadly, the value of big data for firms. In her online pricing work, Professor Lambrecht examines the economics of pricing online services and online promotions, such as daily deals or cashback promotions. Her recently published research explores the role of economics in the context of apparent algorithmic biases. Currently, Professor Lambrecht is studying the value of top positions in organic search results and how users contribute to crowdfunding campaigns. In an additional research stream on price discrimination in service industries, she has focused on the use of multi-part tariffs by service providers such as telecom companies. Professor Lambrecht has published a number of articles in leading academic journals, such as Marketing Science, Management Science, and the Journal of Marketing Research. Among other awards, she has received the American Marketing Association's Paul E. Green Award and has recently been selected as the winner of the prestigious William F. O'Dell Award. In addition, Professor Lambrecht has held several editorial roles at prominent academic publications.
Scott F. Meadow – clinical professor of entrepreneurship at The University of Chicago Booth School of Business and an associate partner at Edgewater Funds – is an expert on entrepreneurial finance, venture capital, and private equity. His teaching focuses on the valuation, security design, structure, due diligence, and financing of private equity and venture capital projects. In addition to his nearly 20 years as a full-time faculty member at Chicago Booth, Professor Meadow has over 25 years of experience as a general partner with private equity and venture capital firms, including William Blair Venture Partners, Frontenac Company, Sprout Group, and most recently with Edgewater Funds – where he remains an associate partner. Over the course of his career, Professor Meadow has approved hundreds of equity financings, where he has been responsible for conducting due diligence and evaluating the due diligence findings of others in order to make investment decisions. His direct investment expertise includes companies in the fields of health care services, consumer services, education, and retail, as well as companies enhanced by the Internet. He has also worked extensively on disputes between general and limited partners. Professor Meadow has served as a testifying expert witness in commercial disputes and is an advisor to numerous venture funds and corporate boards. He currently serves on the boards of Seurat Therapeutics and Dais, and is on the steering committee of the Innovation Fund at The University of Chicago. A recipient of the Richard J. Daley Award, Professor Meadow has also been recognized many times for teaching excellence.
Olivier Toubia – Glaubinger Professor of Business and faculty director of The Eugene Lang Entrepreneurship Center at Columbia Business School – has marketing expertise in the areas of innovation and new product development, with a specific emphasis on market research, behavioral economics, preference measurement, and customer choice models. He focuses his research primarily on studying how firms can optimize their interactions with customers. For example, he has used polyhedral adaptive choice-based conjoint analysis to develop marketing strategy and assessed the comparative value of promotional efforts launched through online social communities versus traditional direct-mail campaigns. Professor Toubia has conducted numerous surveys for litigation – including conjoint studies – involving smartphones, set-top boxes, consumer packaged goods, medical equipment, and perceptions of employment status. He has also been deposed and testified at an arbitration matter. Professor Toubia worked with Applied Marketing Science on the development of IDEALYST®, an online idea generation and group brainstorming tool that has been used by numerous corporations to enhance output and creativity through the use of incentives. His research has been honored with three John D.C. Little Best Paper Awards and published in a variety of marketing outlets. Among other journal affiliations, Professor Toubia is coeditor of Quantitative Marketing and Economics, associate editor of Management Science and Marketing Science, and a member of the editorial boards of International Journal of Research in Marketing and Journal of Marketing Research.
New Managing Principal
Dov Rothman is an economist with expertise in antitrust economics, econometrics, and industrial organization. He has testified as an expert on antitrust issues, and recently led teams that supported the DOJ's testifying economist in its challenge of the Anthem/Cigna merger, the FTC's testifying economist in its challenge of the Sanford Health/Mid Dakota Clinic merger, and the FTC's testifying economist in its challenge of the Penn State Hershey Medical Center/PinnacleHealth merger. Dr. Rothman is an associate editor of the Antitrust Law Journal, and he has published research in outlets including The Antitrust Source, Journal of Health Economics, Journal of Competition Law & Economics, Concurrences: Competition Law Journal, and the ABA Antitrust Section's Econometrics: Legal, Practical and Technical Issues. In addition to his consulting work, Dr. Rothman teaches a course on the economics of merger analysis in the economics department at Harvard University. Prior to joining Analysis Group, Dr. Rothman was an assistant professor at Columbia University.
New Principal
Dave Nellesen specializes in consulting on and applying a range of strategies that address client needs in the development and commercialization of products in the biotechnology, pharmaceutical, molecular diagnostic, and medical device industries. He is an expert in value proposition and evidence strategy, helping clients to develop clinical and economic evidence of value to support launch strategy and secure favorable reimbursement. This work often includes published or unpublished evidence of the value of new products, including evidence dossiers (global value dossiers or AMCP dossiers) and related payer communication tools, health economic models, and peer-reviewed studies. Dr. Nellesen also assists clients in conducting primary research with payers and other stakeholders to assess the value of new technologies and the evidence needed for favorable market access. Prior to joining Analysis Group, Mr. Nellesen spent more than 15 years working directly in the biopharmaceutical industry, where he led a range of commercial strategy engagements, including strategic planning, intellectual property management and valuation, health care compliance, and business process improvement. Among other experience, he has worked as a consultant at PRTM and as a scientist and patent portfolio manager at Incyte Pharmaceuticals.
New Vice President
Claudio Calcagno specializes in applying microeconomics to competition cases. He advises clients on matters including abuse of dominance, vertical and horizontal agreements, mergers and joint ventures, market investigations, state aid, regulatory investigations, and private litigation. These matters often include court proceedings, and Dr. Calcagno is also experienced in leading the support of expert witnesses. He has worked for clients across numerous jurisdictions – including the UK, the EU, Italy, Portugal, Mauritius, Nigeria, South Africa, and Australia. He has experience in a broad range of industries, such as financial services, including retail banking, pensions, insurance, asset management, investment platforms, and credit cards; retail; health care, including pharmaceuticals; technology; consumer goods; professional services; media and communications; energy and environment; commodities; and transportation. In a notable UK engagement, Dr. Calcagno provided economic analysis to private health care operator HCA during a market investigation by the Competition and Markets Authority (CMA) into private health care, HCA's subsequent appeal to the Competition Appeal Tribunal, and the CMA's remittal inquiry. Dr. Calcagno has published in international peer-reviewed academic journals and is coauthor of the textbook Exclusionary Practices: The Economics of Monopolisation and Abuse of Dominance. He frequently speaks at competition policy events and is a guest lecturer at LLM programs. Prior to joining Analysis Group, Dr. Calcagno was an associate director in the economics practice of a Big Four accounting firm. He is fluent in French, Italian, Portuguese, and Spanish.
About Analysis Group
Analysis Group is one of the largest economics consulting firms, with more than 850 professionals across 14 offices in North America, Europe, and Asia. Since 1981, we have provided expertise in economics, finance, health care analytics, and strategy to top law firms, Fortune Global 500 companies, and government agencies worldwide. Our internal experts, together with our network of affiliated experts from academia, industry, and government, offer our clients exceptional breadth and depth of expertise.
